Cue Biopharma (CUE) announced that it has entered into a securities purchase agreement with certain accredited investors for a private placement for gross proceeds of approximately $30M to Cue Biopharma, before placement agent fees and offering expenses. The PIPE financing is expected to close on or about May 4, subject to the satisfaction of customary closing conditions. Newbridge Securities Corporation is acting as placement agent for the PIPE financing.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: